Business Unusual

When unicorns lose their horns

In the technology startup world 90% of projects will fail but investors can’t be sure which will be the one to succeed. When one does, the investment spikes, setting up expectations that a unicorn has been born.

Unicorns are exciting (or at least appear that way) and get lots of media coverage which adds to the hype (See the Hype Cycle) and attracts both those that want to help by getting a job or looking to find if they could copy the idea and try do the same.

Here is the story of a unicorn that may survive the current difficult period or will in time be shown to have never been an actual unicorn in the first place.

Theranos

A medical company that could run over 200 blood tests using the blood drawn from a pin prick and have the results in minutes sounds more like science fiction that fact (more on a tricorder below).

Theranos, a privately-owned medical company, set out to do that and with a $9 billion valuation appeared to have created something amazing. But tests have shown that the results are not as accurate as they needed to be.

The CEO, founder and 50% owner Elizabeth Holmes (32 in 2016), is the youngest female self-made billionaire.

She is an American and was a great student wanting to pursue medicine from early on. She lived for a time in China with her parents and then worked on a bird flu project in Singapore. She had a fear of needles and opted to pursue chemical engineering instead of medicine.

While studying at Stanford University she founded Theranos in 2003 at age 19. She left her studies to pursue the idea of doing extensive blood testing with a process that needed only a fraction of the usual volume of blood and much less time.

The device, called Edison, attracted significant investment (over $400 million, some reports say over $700 million) and partnerships with large companies to manage the blood testing on their behalf.

Holmes and Theranos have 100 patents on their methods and appeared to build on their breakthroughs to capture a significant segment of the medical testing market.

Then, in October 2015, the Wall Street Journal reported that the FDA had carried out an inspection that found the device was inaccurate and only approved its use for one test. It said that the rest of the tests msut be performed using traditional testing systems.

Since then there has been more bad news in the form of a criminal probe to determine if the device is able to do what it claims. The supposed technology and patents have existed for more than a decade now so it is understandable that research papers on the effectiveness and means for doing the tests should be made available (at least to authorities and the scientific community). However, none are currently available.

It would either appear that this unicorn has lost its horn or it is battling a very tough period that one investor claims is motivated by competitors wanting to limit the disruption to the industry.

If it can survive the challenges to its credibility, and demonstrate that it can do the tests accurately with just a pin prick's worth of blood, then Theranos will go on to become as well known as Google and Apple and make Elizabeth Holmes one of the richest people on the planet.

If not, it would serve as a footnote that progress is messy and that medicine, in particular, has had a tough time overcoming challenges to our health.

Time will tell, but as fewer and fewer unicorns are being discovered, venture capital is becoming more circumspect about how it will use the capital. It is significantly down from its high point at the end of 2015. It might mean a slow down for disruption as access to significant capital is a critical part for new start-ups to challenge the incumbents.

Tricorder x Prize

Star Trek fans will recall a device used to determine what was wrong with anyone without touching them. Qualcomm offered $10 million to anyone that could design a device to mimic Dr McCoy's trusted tricorder. It launched in 2013 with 312 teams registering, In May last year that was reduced to seven finalists. The winner will be announced early in 2017 and, assuming the device works, medicine would have boldly gone where no-one had gone before.

Read More
Humans will be returning to the moon, but how will they be fed?

Humans will be returning to the moon, but how will they be fed?

The space race has typically focused on the massive rockets needed to get there, now we need to ensure there is enough to eat.

Defining the Earth we hope to see in 2050

Defining the Earth we hope to see in 2050

Asking what the world will look like in 30 years allows us to start doing what is needed to achieve it.

Bitcoin, Uber and GoPro - how the mighty are challenged - Part 3

Bitcoin, Uber and GoPro - how the mighty are challenged - Part 3

Becoming a world disrupting new technology is not the end of the journey, it may not even be the hardest part.

Bitcoin, Uber and GoPro - how the mighty are challenged - Part 2

Bitcoin, Uber and GoPro - how the mighty are challenged - Part 2

Becoming a world disrupting new technology is not the end of the journey, it may not even be the hardest part.

Bitcoin, Uber and GoPro - how the mighty are challenged - Part 1

Bitcoin, Uber and GoPro - how the mighty are challenged - Part 1

Becoming a world disrupting new technology is not the end of the journey, it may not even be the hardest part.

Are retail shops only going to get smaller now?

Are retail shops only going to get smaller now?

How advances in online retail and delivery options will begin to change the size and nature of physical shops.

Popular articles
Money makes the world go 'round (but sex makes it spin!)

Money makes the world go 'round (but sex makes it spin!)

Bruce Whitfield interviews "Dr Eve" Wasserman about her attitude to money (hopes and fears, successes and failures, etc).

Earn peanuts? How to best invest very small amounts...

Earn peanuts? How to best invest very small amounts...

Got a spare R200 or R300 a month? Here’s how to make that money work hard and grow…

It's not the end of the road... Top tips to improve your matric

It's not the end of the road... Top tips to improve your matric

"Recognise that it’s not the end, it’s the beginning." Expert advise for school-leavers who want to improve their results.

How Naspers paid peanuts for Tencent (China’s most valuable company)

How Naspers paid peanuts for Tencent (China’s most valuable company)

In 2001 Naspers invested $32 million in (then tiny) Tencent. Learn more about the wildly profitable Chinese behemoth...

3 easy questions could bag you R2000!

3 easy questions could bag you R2000!

WIN R2000! But only if you can prove you're a whiz of the MTN Biz Quiz by answering the following three questions...

Blesserfinder: Matching you with a sugar daddy near you

Blesserfinder: Matching you with a sugar daddy near you

Is social trend Blesserfinder, where girls are allegedly matching up with rich 'benefactors' in exchange for sex, a real thing?